Market Analysis
Product Positioning
Competitor Monitoring
Find Global Buyers
Find Contact Information
Company Comparison
Supply Chain Optimization
Email Marketing
Customer Management
Blog
FAQs
About Topease
Agency Program
IndonesiaPT Mersifarma Tirmaku Mercusana, commonly known as "Mersi", is an Indonesian pharmaceutical manufacturer established in 1997. The company initially focused on manufacturing medicines for neuro-psychiatric, psychosomatic, and mental health diseases, later expanding into internal medicine, pulmonary diseases, obstetrics-gynecology, neurosurgery, ear-nose-throat diseases, dentistry, and advanced antibiotic therapeutic agents. It operates in the pharmaceutical preparation manufacturing industry with facilities based in Sukabumi, West Java, and employs roughly 500 to 1,000 people.
| Import | Export |
|---|---|
|
Trade Records
250
|
Trade Records
31
|
|
Suppliers
10
|
Buyers
2
|
|
Latest Import Date
2026-08
|
Latest Export Date
2026-07
|
According to Topease's global trade data, PT. MERSIFARMA TIRMAKU MERCUSANA exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the PT. MERSIFARMA TIRMAKU MERCUSANA distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, PT. MERSIFARMA TIRMAKU MERCUSANA sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore PT. MERSIFARMA TIRMAKU MERCUSANA's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| MOLEAC PTE LTD | PT. MERSIFARMA TIRMAKU MERCUSANA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| OLON S P A | PT. MERSIFARMA TIRMAKU MERCUSANA | 2921 | 24 | $186,500 | 3,420 | Los Angeles |
| UNITED STATES PHARMACOPEIAL CONVENTION | PT. MERSIFARMA TIRMAKU MERCUSANA | 2909 | 24 | $186,500 | 3,420 | Los Angeles |
| AMSTERDAM PHARMA APTEKA RX INC | PT. MERSIFARMA TIRMAKU MERCUSANA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| UNITED STATES PHARMACOPEIA CONVENT | PT. MERSIFARMA TIRMAKU MERCUSANA | 2933 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into PT. MERSIFARMA TIRMAKU MERCUSANA's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| ZUELLIG PHARMA LTD. | PT. MERSIFARMA TIRMAKU MERCUSANA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| ALLIANCE PHARM PTE LTD | PT. MERSIFARMA TIRMAKU MERCUSANA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore PT. MERSIFARMA TIRMAKU MERCUSANA's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access PT. MERSIFARMA TIRMAKU MERCUSANA's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.